Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Outset MedicalOM -8.51%64 PS Ratio is 0.73 as of Aug. 07, 2026, which is 86% below its 10-year median of 5.22. GuruFocus rates OM with a GF Score™ of 64/100 and a GF Value™ of $4.18 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Outset Medical ranks better than 84.31% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Outset Medical's share price is $4.74.
Outset Medical's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $6.46. Hence, Outset Medical's PS Ratio for today is 0.73.
The historical rank and industry rank for Outset Medical's PS Ratio or its related term are showing as below:
OM'
s PS Ratio Range Over the Past 10 Years
Min: 0.21 Med: 5.22 Max: 69.89
Current: 0.74
During the past 8 years, Outset Medical's highest PS Ratio was 69.89. The lowest was 0.21. And the median was 5.22.
OM's PS Ratio is ranked better than 84.31% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.91
vs OM: 0.74
Outset Medical Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Outset Medical was -77.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -39.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -22.20% per year.
During the past 8 years, Outset Medical's highest 3-Year average Revenue per Share Growth Rate was 223.10% per year. The lowest was -39.80% per year. And the median was -0.90% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Outset Medical PS Ratio Related Terms
Outset Medical PS Ratio Historical Data
* Premium members only.
The historical data trend for Outset Medical's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Outset Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Outset Medical PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Outset Medical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Outset Medical's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Outset Medical's Share Price of today is $4.74. Outset Medical's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.46.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Outset Medical (OM) has a PS Ratio of 0.73 as of Aug. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Outset Medical and its competitors. This is 86% below median its historical median of 5.22. Over the past decade, Outset Medical's PS Ratio has ranged from 0.21 to 69.89. According to the industry distribution chart, Outset Medical ranks #126 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 15.7%.
Is Outset Medical's PS Ratio too high?
Outset Medical's current PS Ratio of 0.73 is 86% below median its 10-year median of 5.22. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 69.89. The Medical Devices & Instruments industry median PS Ratio is 2.91. Outset Medical's value of 0.73 is 74.9% below this industry median. Based on the distribution chart, Outset Medical ranks #126 out of 803 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Outset Medical has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Outset Medical's PS Ratio compare to SERA and LNSR?
According to the Medical Devices & Instruments industry distribution chart, Outset Medical ranks #126 out of 803 companies for PS Ratio. This places Outset Medical in the top 16% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.91. Outset Medical's value of 0.73 is 74.9% below this benchmark. Historically, Outset Medical's own PS Ratio has ranged from 0.21 to 69.89 over the past decade. While the company's 10-year median is 5.22 vs. the industry median of 2.91, Outset Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.91, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Outset Medical's current PS Ratio of 0.73 is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Outset Medical and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Outset Medical's current PS Ratio is 0.73, which is 86% below median its own 10-year median of 5.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Outset Medical stock overvalued right now?
Based on GuruFocus' analysis, Outset Medical (OM) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.18, compared to a current price of $4.74 — trading 13.4% above its estimated fair value. The current PS Ratio is 0.73, which is 86% below median its 10-year median of 5.22 and 74.9% below the Medical Devices & Instruments industry median of 2.91. Outset Medical's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Outset Medical (OM), the current PS Ratio is 0.73 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Outset Medical (OM) Overvalued in 2026?
Based on GuruFocus' analysis, Outset Medical stock appears to be overvalued.
The current stock price of $4.74 is trading 13.4% above its estimated GF Value™ of $4.18.
GuruFocus considers Outset Medical to be Modestly Overvalued.
Key valuation signals for OM:
PS Ratio: 0.73 (86% below median its 10-year median of 5.22)
GF Value™: $4.18 vs. price of $4.74 (13.4% above fair value)
Industry Position: 74.9% below the Medical Devices & Instruments median (#126 of 803)
No single metric tells the full story. See the OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
64GF Score
Get the complete analysis for OM
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OM has been successfully added to your 
